Vaccines (May 2024)

Human Papilloma Virus Vaccination and Cervical Screening in the Italian Regions: An Overview of the Current State of the Art

  • Angela Bechini,
  • Claudia Cosma,
  • Giulia Di Pisa,
  • Alice Fanfani,
  • Giulia Ionita,
  • Davide Liedl,
  • Carla Lunetta,
  • Linda Martorella,
  • Silvia Mele,
  • Lorenzo Stacchini,
  • Gabriele Vaccaro,
  • Ornella Zuccaro,
  • Stefano Valente,
  • Gian Marco Prandi,
  • Paolo Bonanni,
  • Sara Boccalini

DOI
https://doi.org/10.3390/vaccines12050504
Journal volume & issue
Vol. 12, no. 5
p. 504

Abstract

Read online

Human Papilloma Virus (HPV) infection and HPV-related cancers can be prevented through vaccinations and mass cervical screening programmes. The Ministry of Health in Italy provides recommendations on primary and secondary prevention of HPV-related diseases, but the 19 Italian regions and 2 autonomous provinces have organisational and decision-making autonomy, with differences in the strategies for offering prevention. The aim of this study is to describe the HPV vaccination and cervical screening offered in all Italian regions. Regional official documents up until 31 December 2021 were first identified. Subsequently, primary and secondary prevention experts from each region were interviewed to validate the previously collected data. The National Immunisation Plan (NIP) 2017–2019 recommends HPV vaccination from the age of 11 for both sexes, with a coverage target of 95%. HPV vaccination is offered free of charge or co-payment. All regions have screening programmes for cervical cancer, using PAP or HPV-DNA tests every three to five years. All regions have an electronic registry for vaccination and screening status. All regions have developed awareness-raising campaigns. It is important to harmonise regional policies with the implementation of information systems integration. The collected data could enhance both regional and national public health initiatives, bolstering the resilience of vaccination programs.

Keywords